Health

Is there a way forward? Accad and Koka interview Paul McHugh, MD, one of the most important figures in academic psychiatry of the last thirty years.

Mention the phrase “industry-sponsored clinical trial” and many eyes will immediately roll back. But, is the reaction justified? Dr. Milton Packer explains.

If you think healthcare pricing seems nonsensical now, just wait until you see what happens when mandated coverage removes any semblance of rational insurance pricing.

The effort to extend the scope of practice of nurse practitioners and physician assistants worries many doctors, who are concerned that patients are getting short-changed in the process. Are these concerns simply motivated by protectionist interests? Dr. Rebekah Bernard discusses this massive push.

Dr. Molly Rutherford illustrates what can be accomplished when physicians are free to care for patients privately, without the stigma associated with addiction and rehabilitation clinics.

Dr. Arvind Cavale, an entrepreneurial endocrinologist from Pennsylvania, explains how a small private practice can remain nimble, adopt technology, and deliver high quality care efficiently.

Dr. Rishi Wadhera on how rigorous science can put healthcare policy under scrutiny and show that the wisdom of the wonks frequently falls short.

Bob and Warren Mosler discuss the assumptions behind Modern Monetary Theory and its implications for economic policy.

James Heathers and his fellow data vigilantes captured the limelight after exposing problems in the work of a world-famous nutrition researcher, which led to the retraction of five papers.

Bob interviews Alex Tabarrok, professor of economics at George Mason University and co-author of the popular Marginal Revolution blog.